Levemir-Body Composition and Energy Metabolism

NCT00862875 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Detemir or Glargine

Sponsor

Institut de Recherches Cliniques de Montreal

Collaborators

[object Object]
[object Object]